Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ADCT — ADC Therapeutics SA

CIK 1000275 TORONTO, A6
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,303
-$17,036 QoQ
Shares Held
5,891
-5.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 113 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 92% Shared 0% None 8%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. ADCT ranks #51 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 9,213,269 $133,500,266
2 ZTS
Zoetis Inc.
 1,828,326 $131,383,499
3 NBIX
Neurocrine Biosciences Inc
 583,476 $98,339,041
4 BHC
Bausch Health Companies Inc.
 10,832,582 $53,404,627
5 VTRS
Viatris Inc
 3,135,460 $49,791,098
6 UTHR
UNITED THERAPEUTICS Corp
 62,600 $33,918,552
7 TEVA
Teva Pharmaceutical Industries Ltd
 953,413 $32,301,629
8 HLN
Haleon plc
 3,385,489 $31,586,609

All Filings in ADCT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,303 5,891
2026-03-31 $23,339 6,224
2025-12-31 $36,227 10,263
2025-09-30 $35,240 8,810
2025-06-30 $13,408 5,003
2025-03-31 $7,159 5,078
2024-12-31 $20,247 10,175
2024-09-30 $40,690 12,918
2024-06-30 $29,826 9,439
2024-03-31 $13,604 3,030
2023-12-31 $6,689 4,030
2023-09-30 $7,250 8,085
2023-06-30 $21,765 10,124
2023-03-31 $13,655 7,003
2022-12-31 $21,617 5,630
2022-09-30 $9,596 1,991
2022-06-30 $11,853 1,491
2022-03-31 $13,088 891
2021-12-31 $9,675 479
2021-09-30 $23,819 877
2021-06-30 $11,614 477
2021-03-31 $10,423 427
2020-09-30 $725 22